Scarica l'app Stockscreener
1.51
5.63%
-0.09
Dopo l'orario di chiusura:
1.51
Precedente Chiudi:
$1.60
Aprire:
$1.66
Volume 24 ore:
236.08K
Relative Volume:
2.01
Capitalizzazione di mercato:
$112.52M
Reddito:
-
Utile/perdita netta:
$-19.57M
Rapporto P/E:
-0.4824
EPS:
-3.13
Flusso di cassa netto:
$-17.24M
1 W Prestazione:
-9.04%
1M Prestazione:
-3.21%
6M Prestazione:
-23.74%
1 anno Prestazione:
-22.16%
Intervallo 1D:
$1.47
$1.6635
Intervallo di 1 settimana:
$1.47
$1.68
Portata 52W:
$1.415
$4.20
Inhibikase Therapeutics Inc Stock (IKT) Company Profile
Nome
Inhibikase Therapeutics Inc
Settore
Industria
Telefono
(302) 295-3800
Indirizzo
1000 N. WEST STREET, SUITE 1200, WILMINGTON
Confronta IKT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IKT
Inhibikase Therapeutics Inc
|
1.51 | 120.72M | 0 | -19.57M | -17.24M | -3.13 |
|
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Inhibikase Therapeutics Inc Stock (IKT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-12 | Downgrade | H.C. Wainwright | Buy → Neutral |
Inhibikase Therapeutics Inc Borsa (IKT) Ultime notizie
Has Inhibikase Therapeutics Inc. formed a bullish divergenceMarket Performance Recap & AI Optimized Trading Strategy Guides - newser.com
Using data tools to time your Inhibikase Therapeutics Inc. exit2025 Short Interest & Real-Time Chart Pattern Alerts - newser.com
Exit strategy if you’re trapped in Inhibikase Therapeutics Inc.July 2025 Decliners & Advanced Technical Analysis Signals - newser.com
Why Inhibikase Therapeutics Inc. stock is a must watch in 20252025 Historical Comparison & Consistent Growth Stock Picks - newser.com
Can trapped investors hope for a rebound in Inhibikase Therapeutics Inc.Short Setup & Advanced Technical Analysis Signals - newser.com
Custom watchlist performance reports with Inhibikase Therapeutics Inc.July 2025 Catalysts & Real-Time Market Trend Scan - newser.com
Will Inhibikase Therapeutics Inc. stock go up soonProfit Target & Consistent Profit Alerts - newser.com
How to read the order book for Inhibikase Therapeutics Inc.Portfolio Gains Summary & Risk Managed Investment Entry Signals - newser.com
Can Inhibikase Therapeutics Inc. stock reach $100 price targetProduct Launch & Real-Time Volume Analysis Alerts - newser.com
Can Inhibikase Therapeutics Inc. stock maintain operating marginsQuarterly Profit Review & Daily Growth Stock Investment Tips - newser.com
How to build a custom watchlist for Inhibikase Therapeutics Inc.July 2025 Reactions & Free High Accuracy Swing Entry Alerts - newser.com
Pattern recognition hints at Inhibikase Therapeutics Inc. upside2025 Trade Ideas & Consistent Growth Equity Picks - newser.com
Developing predictive dashboards with Inhibikase Therapeutics Inc. dataMarket Risk Summary & Technical Confirmation Alerts - newser.com
Why Inhibikase Therapeutics Inc. is moving today2025 Pullback Review & Weekly Market Pulse Alerts - newser.com
Combining price and volume data for Inhibikase Therapeutics Inc.Earnings Miss & Low Drawdown Trading Techniques - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock could be top winnerWeekly Market Summary & Real-Time Market Sentiment Reports - newser.com
Published on: 2025-10-12 03:48:12 - newser.com
Evaluating Inhibikase Therapeutics Inc. with trendline analysis2025 Fundamental Recap & Precise Trade Entry Recommendations - newser.com
How geopolitical risks impact Inhibikase Therapeutics Inc. (IQT0) stock2025 Technical Overview & Fast Momentum Entry Tips - newser.com
Why Inhibikase Therapeutics Inc. (IQT0) stock is a strong analyst pick2025 Short Interest & Daily Profit Focused Screening - newser.com
Is this a good reentry point in Inhibikase Therapeutics Inc.Trade Volume Summary & Free Growth Oriented Trading Recommendations - newser.com
Inhibikase Therapeutics (NASDAQ:IKT) Earns "Sell (D-)" Rating from Weiss Ratings - MarketBeat
Inhibikase Therapeutics Inc Stock Analysis and ForecastHigh Dividend Yield Stocks & Breakthrough Profit Margins - earlytimes.in
What drives Inhibikase Therapeutics Inc IQT0 stock priceVolume Analysis Techniques & Free Explosive Trading Growth - earlytimes.in
Inhibikase Therapeutics Inc. stock outlook for YEARQuarterly Trade Summary & Weekly High Return Stock Opportunities - newser.com
Market reaction to Inhibikase Therapeutics Inc.’s recent news2025 Market Outlook & Fast Entry and Exit Trade Plans - newser.com
What MACD and RSI say about Inhibikase Therapeutics Inc.2025 Retail Activity & Safe Entry Point Alerts - newser.com
Inhibikase Therapeutics Inc Azioni (IKT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Inhibikase Therapeutics Inc Azioni (IKT) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Kush Arvind | Director |
Oct 21 '24 |
Buy |
1.37 |
145,000 |
198,650 |
145,000 |
| Munshi Amit | Director |
Oct 21 '24 |
Buy |
1.37 |
365,000 |
500,050 |
365,000 |
2.96%
0.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):